EUIPO The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.
Protect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark NEUREXPERT was filed as Word mark on 09/17/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/26/2015.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 013262291 |
| Application date | September 17, 2014 |
| Publication date | November 19, 2014 |
| Entry date | February 26, 2015 |
| Expiration date | September 17, 2024 |
Trademark owner
Kemp House, 152-160 City Road
EC1V 2NX London
GB
EC1V 2NX London
GB
Trademark representatives
14 Doctor Staicovici Street, Sector 5
Bucharest
RO
goods and services
9
Scientific apparatus and instruments; apparatus and instruments for pharmaceutical and biological research; apparatus and instruments for cell cultures and stem cells; apparatus and instruments using cell cultures and/or stem cells; apparatus and instruments for research on stem cells; apparatus and instruments for research into regenerative disorders and treatment thereof using cell cultures and/or stem cells; apparatus and instruments for research into stem cells; apparatus and instruments for research into the functional phenotype of stem cells; apparatus and instruments for electrophysiology; apparatus and instruments for electrophysiology and electrophysiological assays and tests; apparatus and instruments for safety testing, new chemical entity screening, automated assay platforms and development of biomarkers; apparatus and instruments for safety testing, new chemical entity screening, automated assay platforms and development of biomarkers all relating to electrophysiology; apparatus and instruments for safety testing, new chemical entity screening, automated assay platforms and development of biomarkers all relating to cell cultures and/or stem cells; apparatus and instruments for the application of cell cultures, stem cells and electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system; apparatus and instruments for neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; apparatus and instruments to research and elucidate the site of action of novel therapeutics within a neuronal network; apparatus and instruments to provide functional and mechanistic data on physiological processes that are or may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing; apparatus and instruments for an in vitro biological model to measure parameters of retinal network activity; apparatus and instruments to define transgenic animal model phenotypes at a cellular and neuronal network level; assays and tests for preclinical research; assays and tests for preclinical research using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for preclinical research; assays and tests for drug discovery; assays and tests for drug discovery using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for drug discovery; assays and tests for research into treatments of nervous system disorders; assays and tests for research into treatments of nervous system disorders using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for research into treatments of nervous system disorders; assays and tests for generating data on biological, organic and non-organic chemical compound potency and efficacy, biological, organic and non-organic chemical mechanism of action, and biological, organic and non-organic chemical functional and mechanistic data; assays and tests for generating data on biological, organic and non-organic chemical compound potency and efficacy, biological, organic and non-organic chemical mechanism of action, and biological, organic and non-organic chemical functional and mechanistic data using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for generating data on biological, organic and non-organic chemical compound potency and efficacy, biological, organic and non-organic chemical mechanism of action, and biological, organic and non-organic chemical functional and mechanistic data; assays and tests for generating data on neural mechanisms underlying higher brain functions, including cognition, attention and sensory processing; electrophysiology and electrophysiological assays and tests for generating data on neural mechanisms underlying higher brain functions, including cognition, attention and sensory processing using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests for measuring biological, organic and non-organic chemical compound potency and efficacy against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins; assays and tests of neuronal function, including synaptic transmission and plasticity; assays and tests of neuronal function, including synaptic transmission and plasticity using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests of neuronal function, including synaptic transmission and plasticity; assays and tests of biological targets in their native environments to provide essential functional and mechanistic data; assays and tests of biological targets in their native environments to provide essential functional and mechanistic data using cell culture and/or stem cells; electrophysiology and electrophysiological assays and tests of biological targets in their native environments to provide essential functional and mechanistic data; assays configured to test the effect of biological, organic and non-organic chemical compounds on neuronal function of biological targets, including ligand-gated ion channels, voltage-gated ion channels, G-protein coupled receptors and biological transporters, to confirm mechanism of action; assays configured to test the effect of biological, organic and non-organic chemical compounds on neuronal function of biological targets, including ligand-gated ion channels, voltage-gated ion channels, G-protein coupled receptors and biological transporters, to confirm mechanism of action using cell culture and/or stem cells; electrophysiology and electrophysiological assays configured to test the effect of biological, organic and non-organic chemical compounds on neuronal function of biological targets, including ligand-gated ion channels, voltage-gated ion channels, G-protein coupled receptors and biological transporters, to confirm mechanism of action; magnetic data carriers, recording discs, compact discs, DVDs and other digital recording media containing scientific data; laboratory consumables for assays using cell cultures and/or stem cells and electrophysiology and electrophysiological assays; the aforesaid not for medical use
37
Installation, maintenance and repair of laboratory equipment for assays and tests using and/or including cell cultures and/or stem cells; installation, maintenance and repair of laboratory equipment for electrophysiology and electrophysiological assays and tests
42
Scientific and technological services and research and design relating thereto; scientific analysis and research services; scientific analysis and research services using cell cultures and/or stem cells to define the action of novel therapeutics in the central nervous system; scientific laboratory, analysis and research services for electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system; scientific laboratory, analysis and research services providing data on biological, organic and non-organic chemical potency, efficacy and mechanism of action at a native biological target in the central nervous system; scientific laboratory, analysis and research services measuring biological, organic and non-organic chemical compound potency against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins in the central nervous system; scientific laboratory, analysis and research services providing functional and mechanistic data on neural mechanisms that underlie higher brain functions, such as cognition, attention and sensory processing; scientific laboratory, analysis and research services to define the phenotype of transgenic models at the cellular and neuronal network level; scientific laboratory, analysis and research services to produce functional and mechanistic data on the physiological processes that may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on neurophysiological diseases, including psychiatry, neurology, neurodegeneration, epilepsy, pain, ophthalmology and retinal neurodegeneration; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on biological targets, including ligand and voltage gated ion channels, G-protein coupled receptors and biological transporters; scientific laboratory services to discover and research the biological site of action of novel therapeutics within a cellular and neuronal network; design and development of assays using cell cultures and/or stem cells; design and development of electrophysiology and electrophysiological assays; design and development of laboratory equipment assays using cell cultures and/or stem cells and laboratory consumables therefor; design and development of laboratory equipment for electrophysiology and electrophysiological assays and laboratory consumables therefor; technical/scientific consultancy services for assays using and/or including cell cultures and/or stem cells; technical/scientific consultancy services for electrophysiology and electrophysiological assays; technical/scientific consultancy services for neurophysiology and neuropharmacology; technical/scientific consultancy services relating to educational and research project progression for all stages of the drug discovery process; technical/scientific consultancy services relating to educational and research study plans in the field of neurophysiology and neuropharmacology; technical/scientific consultancy services relating to analysis and interpretation of experimental findings in the field of neurophysiology and neuropharmacology; technical/scientific consultancy services relating to the establishment and setting up of new laboratories; technical/scientific consultancy services relating to the establishment and setting up of new laboratories using and/or including cell cultures and/or stem cells; technical/scientific consultancy services relating to the establishment and setting up of new electrophysiology laboratories; technical/scientific consultancy services relating to the design and development of assays for diseases and biological targets in the field of neurophysiology and neuropharmacology; technical/scientific consultancy services relating to the preparation of data for the pharmaceutical industry; technical/scientific consultancy services relating to the preparation of data for the pharmaceutical industry generated from cell cultures and/or stem cells; technical/scientific consultancy services relating to the preparation of electrophysiological data for the pharmaceutical industry; technical/scientific consultancy services relating to the design and development of assays for drug discovery; technical/scientific consultancy services relating to the design and development of assays using and/or including cell cultures and/or stem cells for drug discovery; technical/scientific consultancy services relating to the design and development of electrophysiology assays for drug discovery; technical/scientific consultancy services relating to assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; technical/scientific consultancy services relating to assays and tests using and/or including cell cultures and/or stem cells to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; technical/scientific consultancy services relating to electrophysiology and electrophysiological assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; technical/scientific consultancy services relating to equipment purchase, and design and assembly of laboratories for in vitro and in vivo assays and tests; technical/scientific consultancy services relating to equipment purchase, and design and assembly of laboratories using and/or including cell cultures and/or stem cells for in vitro assays and tests; technical/scientific consultancy services relating to equipment purchase, and design and assembly of electrophysiology laboratories for in vitro and in vivo assays and tests; technology and technical/scientific consultancy services to the pharmaceutical industry on clinical and preclinical research in the fields of electrophysiology, neurophysiology and neuropharmacology; technical/scientific consultancy services in neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; technology and technical/scientific consultancy services providing guidance and experimental support for drug discovery research from target identification and validation through to candidate selection and progression to the clinic; advisory services on all applications of electrophysiology, including safety testing, drug screening, automated platforms and development of functional biomarkers
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 20, 2024 | Extension, Notification of expiry of trade mark | ||
| January 22, 2021 | Change Representative, Published | ||
| January 5, 2021 | Change Representative, Published |
ID: 11013262291